Literature DB >> 28126847

Lipids regulate the hydrolysis of membrane bound glucosylceramide by lysosomal β-glucocerebrosidase.

Misbaudeen Abdul-Hammed1,2, Bernadette Breiden1, Günter Schwarzmann1, Konrad Sandhoff3.   

Abstract

Glucosylceramide (GlcCer) is the primary storage lipid in the lysosomes of Gaucher patients and a secondary one in Niemann-Pick disease types A, B, and C. The regulatory roles of lipids on the hydrolysis of membrane bound GlcCer by lysosomal β-glucocerebrosidase (GBA1) was probed using a detergent-free liposomal assay. The degradation rarely occurs at uncharged liposomal surfaces in the absence of saposin (Sap) C. However, anionic lipids stimulate GlcCer hydrolysis at low pH by up to 1,000-fold depending on the nature and position of the negative charges in their head groups while cationic lipids inhibit the degradation, thus showing the importance of electrostatic interactions between the polycationic GBA1 and the negatively charged vesicle surfaces at low pH. Ceramide, fatty acids, monoacylglycerol, and diacylglycerol also stimulate GlcCer hydrolysis while SM, sphingosine, and sphinganine play strong inhibitory roles, thereby explaining the secondary storage of GlcCer in Niemann-Pick diseases. Surprisingly, cholesterol stimulates GlcCer degradation in the presence of bis(monoacylglycero)phosphate (BMP). Sap C strongly stimulates GlcCer hydrolysis even in the absence of BMP and the regulatory roles of the intraendolysosomal lipids on its activity is discussed. Our data suggest that these strong modifiers of GlcCer hydrolysis affect the genotype-phenotype correlation in several cases of Gaucher patients independent of the types.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Gaucher disease; acylglycerols; anionic phospholipids; cationic lipids; cholesterol; electrostatic interaction; fatty acids; lysophospholipids; sphingomyelin; sphingosine

Mesh:

Substances:

Year:  2017        PMID: 28126847      PMCID: PMC5335586          DOI: 10.1194/jlr.M073510

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  88 in total

Review 1.  Molecular and cell biology of acid beta-glucosidase and prosaposin.

Authors:  X Qi; G A Grabowski
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

Review 2.  Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.

Authors:  M T Vanier
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.

Authors:  A M Vaccaro; M Tatti; F Ciaffoni; R Salvioli; A Barca; C Scerch
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

4.  Membrane lipids regulate ganglioside GM2 catabolism and GM2 activator protein activity.

Authors:  Susi Anheuser; Bernadette Breiden; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2015-07-14       Impact factor: 5.922

Review 5.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

Review 6.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

7.  Niemann-Pick disease type C. Pathological, histochemical, ultrastructural and biochemical studies.

Authors:  E F Gilbert; J Callahan; C Viseskul; J M Opitz
Journal:  Eur J Pediatr       Date:  1981-07       Impact factor: 3.183

8.  Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.

Authors:  G Wilkening; T Linke; K Sandhoff
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

9.  Non-neuronopathic Gaucher disease due to saposin C deficiency.

Authors:  A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz
Journal:  Clin Genet       Date:  2007-10-07       Impact factor: 4.438

Review 10.  My journey into the world of sphingolipids and sphingolipidoses.

Authors:  Konrad Sandhoff
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

View more
  9 in total

1.  Membrane lipids and their degradation compounds control GM2 catabolism at intralysosomal luminal vesicles.

Authors:  Susi Anheuser; Bernadette Breiden; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2019-04-15       Impact factor: 5.922

2.  Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic.

Authors:  Todd Logan; Matthew J Simon; Anil Rana; Gerald M Cherf; Ankita Srivastava; Sonnet S Davis; Ray Lieh Yoon Low; Chi-Lu Chiu; Meng Fang; Fen Huang; Akhil Bhalla; Ceyda Llapashtica; Rachel Prorok; Michelle E Pizzo; Meredith E K Calvert; Elizabeth W Sun; Jennifer Hsiao-Nakamoto; Yashas Rajendra; Katrina W Lexa; Devendra B Srivastava; Bettina van Lengerich; Junhua Wang; Yaneth Robles-Colmenares; Do Jin Kim; Joseph Duque; Melina Lenser; Timothy K Earr; Hoang Nguyen; Roni Chau; Buyankhishig Tsogtbaatar; Ritesh Ravi; Lukas L Skuja; Hilda Solanoy; Howard J Rosen; Bradley F Boeve; Adam L Boxer; Hilary W Heuer; Mark S Dennis; Mihalis S Kariolis; Kathryn M Monroe; Laralynne Przybyla; Pascal E Sanchez; Rene Meisner; Dolores Diaz; Kirk R Henne; Ryan J Watts; Anastasia G Henry; Kannan Gunasekaran; Giuseppe Astarita; Jung H Suh; Joseph W Lewcock; Sarah L DeVos; Gilbert Di Paolo
Journal:  Cell       Date:  2021-08-26       Impact factor: 66.850

3.  Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Authors:  Roger Sandhoff; Konrad Sandhoff
Journal:  Adv Neurobiol       Date:  2023

4.  Acat1/Soat1 knockout extends the mutant Npc1 mouse lifespan and ameliorates functional deficiencies in multiple organelles of mutant cells.

Authors:  Maximillian A Rogers; Catherine C Y Chang; Robert A Maue; Elaina M Melton; Andrew A Peden; William S Garver; Junghoon Lee; Peter Schroen; Mitchell Huang; Ta-Yuan Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-04       Impact factor: 12.779

Review 5.  Molecular regulations and therapeutic targets of Gaucher disease.

Authors:  Yuehong Chen; Neetu Sud; Aubryanna Hettinghouse; Chuan-Ju Liu
Journal:  Cytokine Growth Factor Rev       Date:  2018-04-11       Impact factor: 7.638

6.  In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labeling.

Authors:  Jeroen van Smeden; Irini M Dijkhoff; Richard W J Helder; Hanin Al-Khakany; Daphne E C Boer; Anne Schreuder; Wouter W Kallemeijn; Samira Absalah; Herman S Overkleeft; Johannes M F G Aerts; Joke A Bouwstra
Journal:  J Lipid Res       Date:  2017-10-12       Impact factor: 5.922

Review 7.  Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.

Authors:  Bernadette Breiden; Konrad Sandhoff
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

Review 8.  Immunometabolic Activation of Invariant Natural Killer T Cells.

Authors:  Francesca A Ververs; Eric Kalkhoven; Belinda Van't Land; Marianne Boes; Henk S Schipper
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

9.  Gluco-1 H-imidazole: A New Class of Azole-Type β-Glucosidase Inhibitor.

Authors:  Sybrin P Schröder; Liang Wu; Marta Artola; Thomas Hansen; Wendy A Offen; Maria J Ferraz; Kah-Yee Li; Johannes M F G Aerts; Gijsbert A van der Marel; Jeroen D C Codée; Gideon J Davies; Herman S Overkleeft
Journal:  J Am Chem Soc       Date:  2018-04-04       Impact factor: 15.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.